Abstract
□ A method for the determination of cyproheptadine in plasma and urine was developed using the N-ethyl homologue as an internal standard. After extraction of the drug from an alkalinized sample into petroleum ether–isoamyl alcohol, back-extraction into 0.1N HC1, washing the aqueous phase with fresh solvent, re-extraction into petroleum ether after alkalinization, the solvent was evaporated. The reconstituted residue was analyzed by GLC using a SP-2250 column and nitrogen-sensitive detector. Concentrations as low as 3ng/ml could be determined. Plots of peak area of cyproheptadine–peak area of internal standard versus cyproheptadine concentration were linear over the range studied with correlation coefficients of 0.9945 and 0.9924 for plasma and urine, respectively. The method was used to determine the peak time (0.5hr), peak concentration (33ng/ml average), and apparent half-life (3hr) in two dogs after oral administration of 1mg of cyproheptadine/kg.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
